Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $1.29 Million - $1.66 Million
-150,000 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$8.57 - $12.69 $685,600 - $1.02 Million
80,000 Added 114.29%
150,000 $1.35 Million
Q2 2020

Aug 12, 2020

SELL
$8.12 - $13.12 $243,599 - $393,600
-30,000 Reduced 30.0%
70,000 $863,000
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $669,000 - $1.35 Million
100,000 New
100,000 $898,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.